Literature DB >> 12882525

Proteomics approaches to uncover the repertoire of circulating biomarkers for breast cancer.

Bong Kyung Shin1, Hong Wang, Samir Hanash.   

Abstract

There is substantial interest in applying proteomics to cancer biomarker discovery. Proteomics is particularly suited for profiling biological fluids and uncovering circulating markers and is currently being applied to the identification of novel biomarkers for breast cancer. Novel proteomic approaches include direct profiling of serum using mass spectrometry, application of a variety of strategies to harness immunity for cancer diagnosis, protein tagging to capture subproteomes rich in diagnostic markers, the use of protein microarrays, and the use of multi-dimensional liquid protein separation technologies for comprehensive profiling of serum and other biological fluids. It is likely that the application of a wide range of proteomics tools to breast cancer will yield a panel of markers that have utility for breast cancer diagnosis.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12882525     DOI： 10.1023/a:1024038132381

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN： 1083-3021            Impact factor:   2.673


  24 in total

1.  Protein based microarrays: a tool for probing the proteome of cancer cells and tissues.

Authors:  J Madoz-Gúrpide; H Wang; D E Misek; F Brichory; S M Hanash
Journal:  Proteomics       Date:  2001-10       Impact factor: 3.984

Review 2.  Detection technologies in proteome analysis.

Authors:  Wayne F Patton
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-05-05       Impact factor: 3.205

Review 3.  Contribution of proteomics to tumor immunology.

Authors:  F Le Naour
Journal:  Proteomics       Date:  2001-10       Impact factor: 3.984

4.  Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens.

Authors:  Eilon Barnea; Ilan Beer; Renana Patoka; Tamar Ziv; Ofra Kessler; Esther Tzehoval; Lea Eisenbach; Nicholas Zavazava; Arie Admon
Journal:  Eur J Immunol       Date:  2002-01       Impact factor: 5.532

5.  Cancer statistics, 2002.

Authors:  Ahmedin Jemal; Andrea Thomas; Taylor Murray; Michael Thun
Journal:  CA Cancer J Clin       Date:  2002 Jan-Feb       Impact factor: 508.702

6.  Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer.

Authors:  F Le Naour; D E Misek; M C Krause; L Deneux; T J Giordano; S Scholl; S M Hanash
Journal:  Clin Cancer Res       Date:  2001-11       Impact factor: 12.531

7.  DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras.

Authors:  D Nagakubo; T Taira; H Kitaura; M Ikeda; K Tamai; S M Iguchi-Ariga; H Ariga
Journal:  Biochem Biophys Res Commun       Date:  1997-02-13       Impact factor: 3.575

8.  Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.

Authors:  Jinong Li; Zhen Zhang; Jason Rosenzweig; Young Y Wang; Daniel W Chan
Journal:  Clin Chem       Date:  2002-08       Impact factor: 8.327

9.  Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients.

Authors:  Yinsheng Qu; Bao-Ling Adam; Yutaka Yasui; Michael D Ward; Lisa H Cazares; Paul F Schellhammer; Ziding Feng; O John Semmes; George L Wright
Journal:  Clin Chem       Date:  2002-10       Impact factor: 8.327

10.  A survey of the humoral immune response of cancer patients to a panel of human tumor antigens.

Authors:  E Stockert; E Jäger; Y T Chen; M J Scanlan; I Gout; J Karbach; M Arand; A Knuth; L J Old
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307
View more
  8 in total

Review 1.  Tumor-associated antigen arrays for the serological diagnosis of cancer.

Authors:  Carlos A Casiano; Melanie Mediavilla-Varela; Eng M Tan
Journal:  Mol Cell Proteomics       Date:  2006-05-29       Impact factor: 5.911

Review 2.  The sentinel within: exploiting the immune system for cancer biomarkers.

Authors:  Karen S Anderson; Joshua LaBaer
Journal:  J Proteome Res       Date:  2005 Jul-Aug       Impact factor: 4.466

Review 3.  Application and implementation of selective tissue microdissection and proteomic profiling in neurological disease.

Authors:  Jay Jagannathan; Jie Li; Nicholas Szerlip; Alexander O Vortmeyer; Russell R Lonser; Edward H Oldfield; Zhengping Zhuang
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

Review 4.  Emerging affinity-based techniques in proteomics.

Authors:  Shengnan Xie; Colby Moya; Betul Bilgin; Arul Jayaraman; S Patrick Walton
Journal:  Expert Rev Proteomics       Date:  2009-10       Impact factor: 3.940

5.  Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach.

Authors:  Daniel Böhm; Ksenia Keller; Julia Pieter; Nils Boehm; Dominik Wolters; Wulf Siggelkow; Antje Lebrecht; Marcus Schmidt; Heinz Kölbl; Norbert Pfeiffer; Franz-Hermann Grus
Journal:  Oncol Rep       Date:  2012-06-01       Impact factor: 3.906

6.  Potential biomarkers in the sera of breast cancer patients from bahawalpur, pakistan.

Authors:  Faiz-Ul-Hassan Nasim; Samina Ejaz; Muhammad Ashraf; Abdul Rehman Asif; Michael Oellerich; Gulzar Ahmad; Gulzar Ahmad Malik
Journal:  Biomark Cancer       Date:  2012-12-10

7.  Early detection of NSCLC with scFv selected against IgM autoantibody.

Authors:  Tetyana Pedchenko; Ray Mernaugh; Dipti Parekh; Ming Li; Pierre P Massion
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

8.  Protein expression profiling of nuclear membrane protein reveals potential biomarker of human hepatocellular carcinoma.

Authors:  Rizma Khan; Saadia Zahid; Yu-Jui Yvonne Wan; Jameson Forster; A-Bashar Abdul Karim; Atta M Nawabi; Abid Azhar; M Ataur Rahman; Nikhat Ahmed
Journal:  Clin Proteomics       Date:  2013-06-01       Impact factor: 3.988
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.